← Compare landing
Omniabio vs Porton Advanced
Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.
| Category | Omniabio | Porton Advanced |
|---|---|---|
| Summary | OmniaBio is a cell and gene therapy CDMO specializing in process development, analytical development, and GMP manufacturing for lentiviral vectors, iPSCs, and immune cell-based therapies. The company operates a 120,000 sq ft facility in Hamilton, Ontario, integrating AI, automation, and robotics to deliver scalable manufacturing from preclinical to commercial stages. | End-to-end ATMP CDMO provider offering cell engineering, lentiviral vectors, mRNA/LNP, plasmid development, and GMP manufacturing from preclinical through commercialization with 24 IND approvals across NMPA, FDA, and MedSafe. |
| Services |
|
|
| Modalities |
|
|
| Development capabilities |
|
|
| Manufacturing capabilities |
|
|
| Locations |
|
|
| Certifications | Data not yet provided. | Data not yet provided. |
Find similar companies
Markdown mirror: /compare/omniabio/porton-advanced.md